Patron Exim Ltd

AI
Patron Exim Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Patron Exim Ltd

₹ 1.87 0.54%
11 Nov - close price
patronexim.com BSE - SME: 543798
About

Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.[1]

Key Points

Business Overview:[1]
PEL used to do trading of timber, cement sheets and other ancillary business, and also in surgical & non-surgical articles. Currently, company is an ISO 9001:2015, ISO 45001:2018, WHO-GMP, etc. certified trader and distributor of wide range of pharmaceutical raw material like Active Pharmaceutical Ingredients, Industrial, excipient, and solvents

Website BSE
  • Market Cap ₹ 4.33 Cr.
  • Current Price ₹ 1.87
  • High / Low ₹ 4.05 / 1.42
  • Stock P/E
  • Book Value ₹ 16.4
  • Dividend Yield 0.00 %
  • ROCE -2.69 %
  • ROE -2.82 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.11 times its book value
  • Debtor days have improved from 239 to 63.3 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 20.0%
  • Company has a low return on equity of -0.30% over last 3 years.
  • Promoter holding has decreased over last 3 years: -51.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Trading - Chemicals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026 Sep 2026
3.88 9.46 3.50 1.26 5.32 0.00 24.36 23.72 0.49 0.00
3.41 8.87 8.07 4.14 5.18 0.48 24.09 23.74 1.63 0.08
Operating Profit 0.47 0.59 -4.57 -2.88 0.14 -0.48 0.27 -0.02 -1.14 -0.08
OPM % 12.11% 6.24% -130.57% -228.57% 2.63% 1.11% -0.08% -232.65%
1.14 0.25 5.69 2.98 0.66 0.23 0.09 0.04 0.04 0.00
Interest 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Profit before tax 1.49 0.84 1.12 0.10 0.80 -0.25 0.36 0.02 -1.10 -0.09
Tax % 28.86% 28.57% 28.57% 30.00% 26.25% 12.00% 11.11% 50.00% 0.00% 0.00%
1.07 0.59 0.79 0.07 0.59 -0.28 0.32 0.01 -1.10 -0.09
EPS in Rs 0.39 0.34 0.03 0.25 -0.12 0.14 0.00 -0.47 -0.04
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
3.88 12.95 6.58 24.36 24.21 0.49
3.41 16.92 9.33 24.57 25.37 1.71
Operating Profit 0.47 -3.97 -2.75 -0.21 -1.16 -1.22
OPM % 12.11% -30.66% -41.79% -0.86% -4.79% -248.98%
1.14 5.93 3.65 0.32 0.09 0.04
Interest 0.19 0.00 0.00 0.00 0.01 0.00
Depreciation 0.01 0.01 0.00 0.00 0.00 0.01
Profit before tax 1.41 1.95 0.90 0.11 -1.08 -1.19
Tax % 30.50% 29.23% 25.56% 36.36% 0.93%
0.99 1.38 0.67 0.07 -1.09 -1.19
EPS in Rs 0.60 0.29 0.03 -0.47 -0.51
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 23%
TTM: -99%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -461%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -40%
1 Year: -54%
Return on Equity
10 Years: %
5 Years: 1%
3 Years: 0%
Last Year: -3%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 5.34 23.18 23.18 23.18 23.18 23.18
Reserves 0.00 15.29 15.96 16.03 14.94 14.85
0.00 0.03 0.26 0.23 2.09 2.09
5.62 -0.02 5.93 4.81 8.50 8.53
Total Liabilities 10.96 38.48 45.33 44.25 48.71 48.65
0.01 0.01 0.01 0.01 0.04 0.03
CWIP 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 8.67 8.67 8.76 8.84 8.84
10.95 29.80 36.65 35.48 39.83 39.78
Total Assets 10.96 38.48 45.33 44.25 48.71 48.65

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.76 -22.81 -0.26 -0.01 -2.01
0.00 -8.68 0.00 0.00 -0.04
-0.76 31.78 0.23 -0.03 1.86
Net Cash Flow 0.00 0.29 -0.04 -0.04 -0.19
Free Cash Flow 0.76 -22.82 -0.26 -0.01 -2.05
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 253% 560% 1% -14% 172%

Ratios

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 710.24 393.75 561.92 91.55 63.32
Inventory Days 336.84 89.82 308.75 42.61 14.84
Days Payable 537.21 -23.95 625.34 61.07 104.31
Cash Conversion Cycle 509.87 507.52 245.33 73.09 -26.15
Working Capital Days 500.46 831.19 1,674.67 452.80 440.08
ROCE % 8.90% 2.31% 0.28% -2.69%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of permanent employees
count

Log in to view insights

Please log in to see hidden values.

Login
Product portfolio size (APIs, Excipients, Pharma Chemicals & Intermediates)
count (approx.)

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
71.18% 71.18% 71.18% 71.18% 71.18% 20.03% 20.03%
28.83% 28.82% 28.82% 28.82% 28.82% 79.96% 79.96%
No. of Shareholders 7338678478268078551,057

Documents

Announcements

Annual reports